504 related articles for article (PubMed ID: 21901007)
1. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
Zhu Q; Pao GM; Huynh AM; Suh H; Tonnu N; Nederlof PM; Gage FH; Verma IM
Nature; 2011 Sep; 477(7363):179-84. PubMed ID: 21901007
[TBL] [Abstract][Full Text] [Related]
2. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
3. Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer.
Zhu Q; Hoong N; Aslanian A; Hara T; Benner C; Heinz S; Miga KH; Ke E; Verma S; Soroczynski J; Yates JR; Hunter T; Verma IM
Mol Cell; 2018 Jun; 70(5):842-853.e7. PubMed ID: 29861157
[TBL] [Abstract][Full Text] [Related]
4. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
[TBL] [Abstract][Full Text] [Related]
5. Cancer: Let sleeping DNA lie.
Venkitaraman AR
Nature; 2011 Sep; 477(7363):169-70. PubMed ID: 21901006
[No Abstract] [Full Text] [Related]
6. Synergistic lethality between BRCA1 and H3K9me2 loss reflects satellite derepression.
Padeken J; Zeller P; Towbin B; Katic I; Kalck V; Methot SP; Gasser SM
Genes Dev; 2019 Apr; 33(7-8):436-451. PubMed ID: 30804228
[No Abstract] [Full Text] [Related]
7. USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A.
Uckelmann M; Densham RM; Baas R; Winterwerp HHK; Fish A; Sixma TK; Morris JR
Nat Commun; 2018 Jan; 9(1):229. PubMed ID: 29335415
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 is a histone-H2A-specific ubiquitin ligase.
Kalb R; Mallery DL; Larkin C; Huang JT; Hiom K
Cell Rep; 2014 Aug; 8(4):999-1005. PubMed ID: 25131202
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
10. A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor function.
Kononenko AV; Bansal R; Lee NC; Grimes BR; Masumoto H; Earnshaw WC; Larionov V; Kouprina N
Nucleic Acids Res; 2014 Dec; 42(21):e164. PubMed ID: 25260588
[TBL] [Abstract][Full Text] [Related]
11. BRCA1, a 'complex' protein involved in the maintenance of genomic stability.
Savage KI; Harkin DP
FEBS J; 2015 Feb; 282(4):630-46. PubMed ID: 25400280
[TBL] [Abstract][Full Text] [Related]
12. Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells.
Dimitrov SD; Matousková E; Forejt J
Folia Biol (Praha); 2001; 47(4):120-7. PubMed ID: 11508855
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
14. Substrates of the BRCA1-dependent ubiquitin ligase.
Starita LM; Parvin JD
Cancer Biol Ther; 2006 Feb; 5(2):137-41. PubMed ID: 16479151
[TBL] [Abstract][Full Text] [Related]
15. Histone ubiquitination associates with BRCA1-dependent DNA damage response.
Wu J; Huen MS; Lu LY; Ye L; Dou Y; Ljungman M; Chen J; Yu X
Mol Cell Biol; 2009 Feb; 29(3):849-60. PubMed ID: 19015238
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic identification of the BRCA1 ubiquitination substrates.
Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2011 Nov; 10(11):5191-8. PubMed ID: 21950761
[TBL] [Abstract][Full Text] [Related]
17. Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Wen WX; Leong CO
PLoS One; 2019; 14(4):e0215381. PubMed ID: 31022191
[TBL] [Abstract][Full Text] [Related]
18. R-loops and genomic instability in Bre1 (RNF20/40)-deficient cells.
Chernikova SB; Brown JM
Cell Cycle; 2012 Aug; 11(16):2980-4. PubMed ID: 22825248
[TBL] [Abstract][Full Text] [Related]
19. The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.
Dickson KA; Cole AJ; Gill AJ; Clarkson A; Gard GB; Chou A; Kennedy CJ; Henderson BR; ; Fereday S; Traficante N; Alsop K; Bowtell DD; deFazio A; Clifton-Bligh R; Marsh DJ
Hum Mol Genet; 2016 Dec; 25(24):5460-5471. PubMed ID: 27798111
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the centrosome induced by BRCA1 deficiency contributes to tissue-specific carcinogenesis.
Yoshino Y; Fang Z; Qi H; Kobayashi A; Chiba N
Cancer Sci; 2021 May; 112(5):1679-1687. PubMed ID: 33606355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
